Table 3.
NSCLC patients (N = 7) selected for single CTC sequencing.
| Patient ID | NSCLC Stage | Number of CTCs Detected | Number of CTCs Sequenced | Number of WBCs Sequenced | Total Number of Shared Variants Detected in All Sequenced CTCs within the Same Subject |
Total Number of Variants Detected in ≥1 Sequenced CTC within the Same Subject |
|---|---|---|---|---|---|---|
| RL13 | I | 6 | 4 | 2 | 1 | 125 |
| RL5 | I | 3 | 2 | 1 | 85 | 148 |
| RL14 | IV | 3 | 3 | 2 | 72 | 121 |
| RL16 | IV | 237 | 6 | 2 | 130 | 441 |
| RL17 | IV | 7 | 3 | 2 | 91 | 147 |
| RL19 | IV | 2 | 2 | 2 | 137 | 194 |
| RL20 | IV | 3 | 3 | 2 | 101 | 245 |
CTC: circulating tumor cells, WBCs: white blood cells.